NAPROXEN Detail

Drug Name(s):
NAPROXEN

FDA Application No.:
NDA 074121

Active Ingredient(s):
NAPROXEN

Company:
MYLAN

Original Approval or Tentative Approval Date:
May 22, 1994

Products on Application NDA 074121:

Active Ingredients	Strenght	Dosage Form	Marketing Status	TE Code
NAPROXEN	375MG	TABLET; ORAL	Prescription	AB

Welcome

Did you know it can take decades for medical innovations to be widely adopted by the healthcare community? To make the best decisions for your health, you need more information than your physician alone can provide. Medicine.org is here to help you become an advocate for your own health by allowing you to share and discover the current healthcare information you need. Learn more.

Navigation

Resources

Medical Dictionary

Drug Information

Events

«	January 2009
S	M	T	W	T	F	S
				1	2	3
4	5	6	7	8	9	10
11	12	13	14	15	16	17
18	19	20	21	22	23	24
25	26	27	28	29	30	31

Job search

Find jobs in healthcare or try morejob search engines.

About | Privacy Statement | Terms & Conditions | Contact Us | Link Resources

Medicine.org is an online community where consumers can share health resources and information. It is intended to supplement, not replace, professional medical care. Always consult your doctor for medical advice related to your specific health condition.

We comply with the HONcode standard for health trust worthy information:
verify here.

Links to Site

last updated on 01-07-2009

NAPROXEN Detail

Sponsored Links

Recall Notices

Action Alerts

Active forum topics

Poll

Subscribe to our feed